Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array

Cancer Genetics and Cytogenetics

Volumn 166, Issue 1, 2006, Pages 56-64

  Park, Sang Jin ^a   Jeong, Seon Yong ^a   Kim, Hyon J ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENOMICS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; KARYOTYPE; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; Y CHROMOSOME;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, Y; DNA, NEOPLASM; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIVER NEOPLASMS; MICROARRAY ANALYSIS; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

HEPATITIS B VIRUS;

EID: 33645983981     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.08.022     Document Type: Article

References (39)

1. Staib F., Hussain S.P., Hofseth L.J., Wang X.W., and Harris C.C. TP53 and liver carcinogenesis. Hum Mutat 21 (2003) 201-216
2. Huh K., Choi S.Y., Whang Y.S., and Lee D.S. Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J Korean Med Sci 13 (1998) 306-310
3. Tarao K., Ohkawa S., Shimizu A., Harada M., Nakamura Y., Ito Y., Tamai S., Hoshino H., Okamoto N., Iimori K., Inoue T., and Kanisawa M. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 72 (1993) 369-374
4. Lui W.Y., Lin H.L., Chau G.Y., Liu T.Y., and Chi C.W. Male predominance in hepatocellular carcinoma: new insight and a possible therapeutic alternative. Med Hypotheses 55 (2000) 348-350
5. Schafer D.F., and Sorrell M.F. Hepatocellular carcinoma. Lancet 353 (1999) 1253-1257
6. Nagasue N., and Kohno H. Hepatocellular carcinoma and sex hormones. HPB Surg 6 (1992) 1-6
7. Balsara B.R., Pei J., De Rienzo A., Simon D., Tosolini A., Lu Y.Y., Shen F.M., Fan X., Lin W.Y., Buetow K.H., London W.T., and Testa J.R. Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer 30 (2001) 245-253
8. Guan X.Y., Fang Y., Sham J.S., Kwong D.L., Zhang Y., Liang Q., Li H., Zhou H., and Trent J.M. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29 (2000) 110-116
9. Kusano N., Shiraishi K., Kubo K., Oga A., Okita K., and Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29 (1999) 1858-1862
10. Wang G., Zhao Y., Liu X., Wang L., Wu C., Zhang W., Liu W., Zhang P., Cong W., Zhu Y., Zhang L., Chen S., Wan D., Zhao X., Huang W., and Gu J. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 31 (2001) 221-227
11. Niketeghad F., Decker H.J., Caselmann W.H., Lund P., Geissler F., Dienes H.P., and Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 85 (2001) 697-704
12. Zimmermann U., Feneux D., Mathey G., Gayral F., Franco D., and Bedossa P. Chromosomal aberrations in hepatocellular carcinomas: relationship with pathological features. Hepatology 26 (1997) 1492-1498
13. Parada L.A., Hallen M., Tranberg K.G., Hagerstrand I., Bondeson L., Mitelman F., and Johansson B. Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes Chromosomes Cancer 23 (1998) 26-35
14. Takeo S., Arai H., Kusano N., Harada T., Furuya T., Kawauchi S., Oga A., Hirano T., Yoshida T., Okita K., and Sasaki K. Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet 130 (2001) 127-132
15. Hwang H.J., Kim G.J., Lee G.B., Oh J.T., Chun Y.H., and Park S.H. A comprehensive karyotypic analysis on Korean hepatocellular carcinoma cell lines by cross-species color banding and comparative genomic hybridization. Cancer Genet Cytogenet 141 (2003) 128-137
16. Zimonjic D.B., Keck C.L., Thorgeirsson S.S., and Popescu N.C. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29 (1999) 1208-1214
17. Jordan J.J., Hanlon A.L., Al-Saleem T.I., Greenberg R.E., and Tricoli J.V. Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 124 (2001) 122-126
18. Perinchery G., Sasaki M., Angan A., Kumar V., Carroll P., and Dahiya R. Deletion of Y-chromosome specific genes in human prostate cancer. J Urol 163 (2000) 1339-1342
19. Wallrapp C., Hahnel S., Boeck W., Soder A., Mincheva A., Lichter P., Leder G., Gansauge F., Sorio C., Scarpa A., and Gress T.M. Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. Int J Cancer 91 (2001) 340-344
20. Kujawski M., Jarmuz M., Rydzanicz M., Szukala K., Wierzbicka M., Grenman R., Golusinski W., and Szyfter K. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region. Cancer Lett 208 (2004) 95-101
21. Lau Y.F., and Zhang J. Expression analysis of thirty-one Y chromosome genes in human prostate cancer. Mol Carcinog 27 (2000) 308-321
22. Park J.G., Lee J.H., Kang M.S., Park K.J., Jeon Y.M., Lee H.J., Kwon H.S., Park H.S., Yeo K.S., Lee K.U., Kim S.T., Chung J.K., Hwang Y.J., Lee H.S., Kim C.Y., Lee Y.I., Chen T.R., Hay R.J., Song S.Y., Kim W.H., Kim C.W., and Kim Y.I. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer 62 (1995) 276-282
23. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., and Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
24. Yano S., Matsuyama H., Matsuda K., Matsumoto H., Yoshihiro S., and Naito K. Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. Cancer Genet Cytogenet 150 (2004) 122-127
25. Inazawa J., Inoue J., and Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95 (2004) 559-563
26. Wong N., Lam W.C., Lai P.B., Pang E., Lau W.Y., and Johnson P.J. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 159 (2001) 465-471
27. Wong N., Chan A., Lee S.W., Lam E., To K.F., Lai P.B., Li X.N., Liew C.T., and Johnson P.J. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. J Hepatol 38 (2003) 298-306
28. Hashimoto K., Mori N., Tamesa T., Okada T., Kawauchi S., Oga A., Furuya T., Tangoku A., Oka M., and Sasaki K. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 17 (2004) 617-622
29. Ueki T., Fujimoto J., Suzuki T., Yamamoto H., and Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25 (1997) 862-866
30. Bando K., Nagai H., Matsumoto S., Koyama M., Kawamura N., Onda M., and Emi M. Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 25 (1999) 284-289
31. Shaul Y., Garcia P.D., Schonberg S., and Rutter W.J. Integration of hepatitis B virus DNA in chromosome-specific satellite sequences. J Virol 59 (1986) 731-734
32. Wu Y., Xue Y., and Pan J. Y-chromosome loss in acute promyelocytic leukemia. Cancer Genet Cytogenet 157 (2005) 90-91
33. United Kingdom Cancer Cytogenetics Group. Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer 5 (1992) 83-88
34. Guttenbach M., Koschorz B., Bernthaler U., Grimm T., and Schmid M. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am J Hum Genet 57 (1995) 1143-1150
35. Jin C., Jin Y., Wennerberg J., Akervall J., Grenthe B., Mandahl N., Heim S., Mitelman F., and Mertens F. Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat Res 374 (1997) 63-72
36. Yuan X., Lu M.L., Li T., and Balk S.P. SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 276 (2001) 46647-46654
37. Lau Y.F. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 64 (1999) 921-927
38. Lahn B.T., and Page D.C. A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins. Hum Mol Genet 9 (2000) 311-319
39. Schiebel K., Mertz A., Winkelmann M., Glaser B., Schempp W., and Rappold G. FISH localization of the human Y-homolog of protein kinase PRKX (PRKY) to Yp11.2 and two pseudogenes to 15q26 and Xq12→q13. Cytogenet Cell Genet 76 (1997) 49-52